Stay updated on Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-04-30T14:15:39.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect a new study protocol for ovarian cancer treatments, including the addition of new drugs and the removal of previous treatment details. Key identifiers and collaborators have been retained, indicating a shift in focus towards a revised treatment regimen.
    Difference
    23%
    Check dated 2025-04-16T08:19:39.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.0%
    Check dated 2025-04-09T02:22:05.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.0%
    Check dated 2025-03-30T19:06:28.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.4%
    Check dated 2025-03-01T20:53:20.000Z thumbnail image
  9. Check
    103 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a new version (v2.14.2) and includes a notice about heavy traffic affecting some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    0.5%
    Check dated 2025-02-07T07:39:20.000Z thumbnail image

Stay in the know with updates to Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial page.